These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37908671)

  • 61. M1 Macrophage-Derived Sonoresponsive Nanoparticles for Sonodynamic Anticancer Therapy.
    Chen S; Wang J; Liao H; Tang K; Xu Y; Wang L; Niu C
    Int J Nanomedicine; 2022; 17():4725-4741. PubMed ID: 36246937
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Hierarchical Structured Fiber Device Remodeling the Acidic Tumor Microenvironment for Enhanced Cancer Immunotherapy.
    Li Y; Yuan R; Luo Y; Guo X; Yang G; Li X; Zhou S
    Adv Mater; 2023 May; 35(21):e2300216. PubMed ID: 36912443
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
    Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
    Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy.
    Rodell CB; Ahmed MS; Garris CS; Pittet MJ; Weissleder R
    Theranostics; 2019; 9(26):8426-8436. PubMed ID: 31879528
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
    Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
    Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Doxorubicin-Near infrared dye conjugate induces immunogenic cell death to enhance cancer immunotherapy.
    Jin C; Wang Y; Li Y; Li J; Zhou S; Yu J; Wang Z; Yu Y; Zhang H; Wang D; He Z; Wang Y
    Int J Pharm; 2021 Sep; 607():121027. PubMed ID: 34418473
    [TBL] [Abstract][Full Text] [Related]  

  • 67. G250 Antigen-Targeting Drug-Loaded Nanobubbles Combined with Ultrasound Targeted Nanobubble Destruction: A Potential Novel Treatment for Renal Cell Carcinoma.
    Yu Z; Wang Y; Xu D; Zhu L; Hu M; Liu Q; Lan W; Jiang J; Wang L
    Int J Nanomedicine; 2020; 15():81-95. PubMed ID: 32021166
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Heat-Confined Tumor-Docking Reversible Thermogel Potentiates Systemic Antitumor Immune Response During Near-Infrared Photothermal Ablation in Triple-Negative Breast Cancer.
    Revuri V; Rajendrakumar SK; Park MS; Mohapatra A; Uthaman S; Mondal J; Bae WK; Park IK; Lee YK
    Adv Healthc Mater; 2021 Nov; 10(21):e2100907. PubMed ID: 34541833
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multifunctional Liposomes Remodeling Tumor Immune Microenvironment for Tumor Chemoimmunotherapy.
    Li X; Luo Y; Huang Z; Wang Y; Wu J; Zhou S
    Small Methods; 2023 May; 7(5):e2201327. PubMed ID: 37075716
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy.
    Mao Q; Min J; Zeng R; Liu H; Li H; Zhang C; Zheng A; Lin J; Liu X; Wu M
    Theranostics; 2022; 12(14):6088-6105. PubMed ID: 36168633
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
    Chen Y; Bei J; Chen M; Cai W; Zhou Z; Cai M; Huang W; Lin L; Guo Y; Liu M; Huang X; Xiao Z; Xu Z; Zhu K
    Adv Healthc Mater; 2024 Mar; 13(6):e2303031. PubMed ID: 37848188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma.
    Yang H; Jing H; Han X; Tan H; Cheng W
    Drug Des Devel Ther; 2021; 15():531-542. PubMed ID: 33603343
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages.
    Zhang Y; Chen Y; Li J; Zhu X; Liu Y; Wang X; Wang H; Yao Y; Gao Y; Chen Z
    ACS Appl Mater Interfaces; 2021 Jun; 13(21):24442-24452. PubMed ID: 34008947
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tannins in Terminalia bellirica inhibits hepatocellular carcinoma growth via re-educating tumor-associated macrophages and restoring CD8
    Chang Z; Zhang Q; Hu Q; Liu Y; Zhang L; Liu R
    Biomed Pharmacother; 2022 Oct; 154():113543. PubMed ID: 36057223
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sinoporphyrin sodium based sonodynamic therapy induces anti-tumor effects in hepatocellular carcinoma and activates p53/caspase 3 axis.
    Li E; Sun Y; Lv G; Li Y; Zhang Z; Hu Z; Cao W
    Int J Biochem Cell Biol; 2019 Aug; 113():104-114. PubMed ID: 30660690
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bibliometric study of immunotherapy for hepatocellular carcinoma.
    Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
    Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Arginine-assembly as NO nano-donor prevents the negative feedback of macrophage repolarization by mitochondrial dysfunction for cancer immunotherapy.
    Zheng X; Liu Y; Liu Y; Zang J; Wang K; Yang Z; Chen N; Sun J; Huang L; Li Y; Xue L; Zhi H; Zhang X; Yu M; Chen S; Dong H; Li Y
    Biomaterials; 2024 Apr; 306():122474. PubMed ID: 38271788
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acidic microenvironment responsive polymeric MOF-based nanoparticles induce immunogenic cell death for combined cancer therapy.
    Zhang X; Lu Y; Jia D; Qiu W; Ma X; Zhang X; Xu Z; Wen F
    J Nanobiotechnology; 2021 Dec; 19(1):455. PubMed ID: 34963499
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
    Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
    J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.